Promising Prognosis Marker Candidates on the Status of Epithelial–Mesenchymal Transition and Glioma Stem Cells in Glioblastoma

MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma

(2019) Yasuo Takashima et al.   PLoS One

CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme

(2019) Yasuo Takashima et al.   PLoS One

Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL

(2019) Yasuo Takashima et al.   Scientific Reports

Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells

(2019) Yasuo Takashima et al.   BMC CANCER

Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics

(2019) Silantyev et al.   Cells

Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells

(2018) Chung-Ching Chio et al.   BMC CANCER

Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer

(2018) Ryong Kim et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Role of extracellular vesicles in glioma progression

(2018) Claudia Quezada et al.   MOLECULAR ASPECTS OF MEDICINE

β-Asarone Inhibits Invasion and EMT in Human Glioma U251 Cells by Suppressing Splicing Factor HnRNP A2/B1

(2018) et al.   MOLECULES

Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication

(2018) Yasuo IWADATE   NEUROLOGIA MEDICO-CHIRURGICA

Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma

(2018) Yasuo Takashima et al.   Oncotarget

Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma

(2018) Yasuo Takashima et al.   Oncotarget

Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway

(2018) Haibin Wu et al.   ONCOLOGY REPORTS

Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition

(2017) Y. Rajesh et al.   EXPERIMENTAL CELL RESEARCH

Cell biology-metabolic crosstalk in glioma

(2017) Alison Colquhoun   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Molecular markers in glioma

(2017) Kirsten Ludwig et al.   JOURNAL OF NEURO-ONCOLOGY

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression

(2017) Davide Pradella et al.   Molecular Cancer

Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation

(2017) Elizabeth Allen et al.   Science Translational Medicine

Automatic digital quantification of bone marrow myeloma volume in appendicular skeletons - clinical implications and prognostic significance

(2017) Yuki Nishida et al.   Scientific Reports

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Tumor vasculature and glioma stem cells: Contributions to glioma progression

(2016) Niyati Jhaveri et al.   CANCER LETTERS

Optimized dissociation protocol for isolating human glioma stem cells from tumorspheres via fluorescence-activated cell sorting

(2016) Donglai Lv et al.   CANCER LETTERS

Stem cell markers in glioma progression and recurrence

(2016) Kirsten Hattermann et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Classification of adult diffuse gliomas by molecular markers—a short review with historical footnote

(2016) Ryohei Otani et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation

(2016) Isabele C. Iser et al.   MEDICINAL RESEARCH REVIEWS

Epithelial-mesenchymal transition in glioblastoma progression

(2016) YASUO IWADATE   Oncology Letters

Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma

(2016) Zheng Wang et al.   OncoImmunology

PD-L1 expression and prognostic impact in glioblastoma

(2015) Edjah K. Nduom et al.   NEURO-ONCOLOGY

Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide

(2014) Johan A F Koekkoek et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Gene expression signature-based prognostic risk score in patients with glioblastoma

(2013) Atsushi Kawaguchi et al.   CANCER SCIENCE

Gene Expression Signature-Based Prognostic Risk Score in Patients with Primary Central Nervous System Lymphoma

(2012) A. Kawaguchi et al.   CLINICAL CANCER RESEARCH

Survival comparison between glioblastoma multiforme and other incurable cancers

(2010) B. Tran et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Biomarkers for epithelial-mesenchymal transitions

(2009) Michael Zeisberg et al.   JOURNAL OF CLINICAL INVESTIGATION

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Random survival forests

(2008) Hemant Ishwaran et al.   Annals of Applied Statistics